UK Markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
161.95-7.79 (-4.59%)
At close: 4:00PM EDT
162.25 +0.30 (+0.19%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close169.74
Bid161.09 x 1200
Ask161.82 x 800
Day's range160.33 - 170.74
52-week range76.59 - 331.68
Avg. volume5,099,066
Market cap12B
Beta (5Y monthly)1.62
PE ratio (TTM)N/A
EPS (TTM)-9.51
Earnings date10 May 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est264.20
  • Motley Fool

    5 of the Fastest-Growing Stocks On the Planet

    For instance, AMC Entertainment (NYSE: AMC) reported 2,252% revenue growth in its most recent quarter. Last year at this time, the COVID-19 lockdown was crushing a lot of stocks, with revenues dropping to near-zero for many companies. While some of these stocks are "turn around" stories, all of the stocks in this article have strong financials and are way safer than AMC.

  • Motley Fool

    Why Shares of Moderna, Novavax, and Ocugen Are Falling Today

    Shares of Moderna (NASDAQ: MRNA) are off by 3.4%; Novavax (NASDAQ: NVAX) is down 5.1%; and Ocugen's (NASDAQ: OCGN) stock is in the red by a jaw-dropping 13.3%, all as of 3:34 p.m. EDT Friday. The U.S. Food and Drug Administration (FDA) might delay the decision on Moderna's jab for adolescents due to safety issues, according to a report from the Wall Street Journal.

  • Yahoo Finance Video

    NIH Director on FDA ‘being careful’ in clearing Moderna vaccine for kids 12-17

    Dr. Francis Collins, Outgoing NIH Director, joins Yahoo Finance’s Anjalee Khemlani to discuss Covid-19 vaccine production, drug development research, and misinformation surrounding Covid-19 vaccines.